Form 4: CRISPR Therapeutics CFO Reports Stock Transactions
SEC Form 4
Chief Financial Officer of CRISPR Therapeutics, Raju Prasad, reports acquisition and disposal of common shares and derivative securities.
Summary
- On March 14, 2025, Raju Prasad, the CFO of CRISPR Therapeutics, reported transactions involving common shares and derivative securities.
- Prasad acquired 10,000 common shares through the vesting of restricted stock units.
- He also disposed of 3,762 common shares on March 17, 2025, at a price of $41.8 per share to cover tax withholding obligations.
- Additionally, Prasad was granted a stock option to purchase 36,666 common shares at an exercise price of $42.12 on March 14, 2025.
- He also received 27,500 restricted stock units on March 14, 2025, which will vest in quarterly installments.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing primarily reflects routine stock transactions related to executive compensation. There is no indication of positive or negative sentiment towards the company's prospects.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership by a key executive.
- Employees who are also shareholders may be impacted by the vesting of restricted stock units.
Key Dates
| Date | Description |
|---|---|
| 03/14/2023 | Date of original restricted stock unit award for 40,000 shares. |
| 03/14/2024 | First vesting date for one quarter of the 40,000 shares from the March 14, 2023 RSU award. |
| 03/14/2025 | Date of transaction: Acquisition of shares via RSU vesting, grant of stock options and additional RSUs. |
| 03/17/2025 | Date of transaction: Disposal of shares to cover tax withholding. |
| 03/18/2025 | Date of filing. |
| 04/14/2025 | First vesting date for the stock options granted on March 14, 2025. |
| 03/14/2026 | First vesting date for one quarter of the 27,500 shares from the March 14, 2025 RSU award. |
| 03/14/2027 | Second vesting date for one quarter of the 27,500 shares from the March 14, 2025 RSU award. |
| 03/14/2028 | Third vesting date for one quarter of the 27,500 shares from the March 14, 2025 RSU award. |
| 03/14/2029 | Fourth vesting date for one quarter of the 27,500 shares from the March 14, 2025 RSU award. |
| 03/14/2035 | Expiration date of the stock options granted on March 14, 2025. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.